This study reports that TNF-a is a potent mitogen for human bone marrow sternal cells in vitro (assessed by [ 3 H]-thymidine incorporation into DNA and cell counts). In contrast, cytokines such as IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-6, LIF, SCF, M-CSF, G-CSF and GM-CSF had no effect. The effect of TNF-a on the growth of human bone marrow stromal cells could be of importance during in ammatory processes which take place in the marrow, for ex ample marrow brosis.
Introduction
Bone marrow stromal cells (mostly broblastlike cells) regulate hematopoiesis by producing cytokines and colony-stimulating factors (CSFs). 1, 2 While numerous studies highlight the effects of stromal cell-derived cytokines on the growth of human hematopoietic progenitors, 3, 4 less information is available on the role of cytokines and CSFs on the growth of marrow stromal cells. Tumour necrosis factor alpha (TNF-a) is a pleiotropic cytokine which mediates numerous biological responses such as immunomodulation, in ammation and antimicrobial defence. 5 Among its effects, TNF-a plays a role in the regulation of myelopoiesis, erythropoiesis, lymphopoiesis and thrombocytopoiesis. 6 since TNF-a is a mitogen for human dermal, foreskin and lung broblasts, 7 -9 we have investigated its effect on human bone marrow stromal cell proliferation.
Materials and Methods
This study was performed according to the Helsinki recommendations. Cultures of human bone marrow sternal cells were established from stromal bone marrow samples harvested from untreated patients referred for diagnosis. Mononuclear marrow cells were isolated by separation on a Ficoll gradient (400 3 g 20 min), washed twice with HBSS (400 3 g , 10 min), and seeded in 75 cm 2 culture asks (2 3 10 6 cells/ ml; 5 3 10 5 cells/ cm 2 ) in RPMI 1640 with 20% FCS (Gibco, Cergy Pontoise, France), penicillin (100 U/ ml) and streptomycin (100 mg/ ml) (culture medium) at 378 C in 5% CO 2 in air as previously described. 10 After 1 week, non-adherent cells were removed from culture asks. Adherent cells were grown to con uence for 3 ±4 weeks with weekly changes of medium and were subcultured after trypsin treatment. Cells were analysed on a Pro le Coulter using Epics Pro le Software to determine the cellular characteristics of the adherent layers. As previously reported, 11 more than 99.8%of cells were CD2 -and CD22 -indicating the absence of T and B cells on the layers and 4%of cells were CD14 + and CD33 + indicating a monocytic lineage. Cells (1 3 10 4 / well) were plated for 24 hours in 96-well plates in 100 ml of culture medium. Adherent cells were washed with HBSS and 200 ml of serum-free medium was added to each well for 2 days. Adherent cells were reactivated with 100 ml of RPMI 1640 with 5% FCS and stimulated with TNF-a, interleukin-1a (IL-1a), IL-1b, IL-2 (Tebu, Le Perray en Yvelines, France), IL-3 (Sandoz, Rueil-Malmaison, France), IL-4 (Shering Plough Co.), IL-6, leukaemia inhibitory factor (LIF), stem cell factor (SCF) (Tebu), macrophage-CSF (M-CSF) (Cetus Corporation Emeryville, CA), granulocyte-CSF (G-CSF) (Sandoz), and granulocyte ±macrophage CSF (GM-CSF) (R & D Systems, Oxon, UK) or the appropriate vehicle (10 ml RPMI). After 60 hours of incubation, cultures (six replicates per sample) were pulsed for 12 hours with 1 mCi/ ml [ 3 H]-thymidine and the cells were harvested using a Skatron cell harvester. In separate sets of experiments, cells (four replicates per sample) were harvested after trypsin treatment (0.05%trypsin for 5 min at 378 C) and counted by using a haemocytometer. In some experiments the effect of TNF-a was investigated with cells reactivated with 20% FCS and with cells grown in 5%FCS without the step of serum-deprivation. In other experiments TNF-a was added 24 hours after reactivation with 5% FCS.
Results were compared with the Mann ±Whit-ney U-test or Student's t test for paired samples. A P , 0·05 was considered signi cant.
Results and Discussion
These experiments were done with marrow stromal cells from 25 different donors. Previous experiments showed that FCS increased [ 3 H]-thymidine incorporation by human bone marrow stromal cells in a dose-dependent manner with 5% FCS and 20% FCS as suboptimal and optimal concentrations, respectively. 2 In growth synchronized cells, TNF-a at 1 ng/ ml increased DNA synthesis by 230 61% (Fig. 1) . In similar experimental conditions (i.e., 5% FCS in growth medium), IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-6, LIF, SCF, G-CSF, GM±CSF (both from 10 ng/ ml to 0·1 ng/ ml) and M-CSF (from 1000 Ul/ ml to 10 Ul/ ml) had no signi cant effect ( P . 0·05) on DNA synthesis (data not shown). The stimulatory effect of TNF-a at 1 ng/ ml was found with cells from 15 of 15 different donors but was not observed with non-synchronized cells (data not shown). In growth medium with 20% FCS, TNF-a stimulated [ 3 H]-thymidine incorporation by 51 9% (mean SEM of three experiments). Since the greatest increase was seen with 5% FCS in medium, we focused on this concentration for the remainder of the experiments.
We next assessed whether the observed stimulation of DNA synthesis was dependent on the time of TNF-a addition. When TNF-a was added 24 hours after reactivation with FCS, a signi cant (P , 0·05, four experiments) increase in [ 3 H]-thymidine incorporation was found in TNF-a-treated cells (2552 506 dpm) as compared with controls (1552 522 dpm) indicating that serum-stimulated marrow stromal cells can be further regulated by TNF-a.
[ 3 H]-thymidine uptake is considered a good index of cell proliferation but may also, in part, re ect intracellular events other than cell division such as difusion of DNA precursors. 12 Therefore, we assessed the effect of TNF-a on cell number. As shown in Fig. 1B , a signi cant increase of marrow stromal cell number was found 3 days after TNF-a stimulation.
This study indicates that numerous cytokines and growth factors, which act positively or negatively on the growth of human marrow progenitors, have no effect on the growth of human marrow stromal cells. Among the 12 molecules tested in this study, only TNF-a is a potent mitogenic stimulus for their growth. This 7 -9 These results highlight for the rst time a mechanism which could be of importance for understanding the increased population and activity of bone marrow broblasts in marrow brosis associated with several haematological malignancies.
